John C Ayres - SEE REMARKS, Aratana Therapeutics, Inc
As of July 18, 2019
What is John C Ayres's Net Worth?
The current estimated net worth of Aratana Therapeutics, Inc's SEE REMARKS, John C Ayres, is estimated to be about $13.09K . John C Ayres owns about 129,889 units of Aratana Therapeutics, Inc common stock. In the last 6 months at Aratana Therapeutics, Inc, John C Ayres has sold an estimated value of $13.09K worth.
What is John C Ayres's Past Insider Trading?
John C Ayres's largest sale order was 3,125 units , worth over $13.09K on February 1, 2019. In total, John C Ayres has made about 3 transactions over 6 months of their time at Aratana Therapeutics, Inc. John C Ayres usually trades in January, February and July, with the busiest year in 2019.
John C Ayres
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is John C Ayres's' Mailing Address?
- Mailing address is C/o Aratana Therapeutics, Inc. 11400 Tomahawk Creek Parkway, Suite 340 Leawood KS 66211 KS
Aratana Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Steven St. Peter, M.D. | 2018 | $528,390 | $654,948 | $649,006 | $247,000 | $11,000 | $2,090,344 |
| Steven St. Peter, M.D. | 2017 | $513,000 | $1,121,998 | $982,434 | $213,000 | $10,800 | $2,841,232 |
| Craig A. Tooman | 2018 | $360,000 | $191,751 | $189,953 | $110,900 | $11,000 | $863,604 |
| Craig A. Tooman | 2017 | $360,000 | $245,412 | $238,970 | $95,100 | $10,800 | $950,282 |
| Brent Standridge | 2018 | $315,000 | $191,751 | $189,953 | $92,100 | $11,000 | $799,804 |
| Brent Standridge | 2017 | $307,500 | $109,072 | $106,209 | $81,300 | $10,800 | $614,881 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1509190/000150919019000027/petx-20190419xdef14a.htm
What are Aratana Therapeutics, Inc's Past Insider Trades?
Aratana Therapeutics, Inc's most recent insider trade came on February 1, 2019 by John C Ayres who sold 3,125 units worth $13.09K . In the last 6 years, insiders at Aratana Therapeutics, Inc have sold an estimated value of $68.33M and bought an estimated value of $12.01M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are StSt, PRESIDENT AND CEO, Ernst Heinen, Chief Development Officer, and Julia A Stephanus, CHIEF COMMERCIAL OFFICER .
ARATANA THERAPEUTICS, INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||